miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 26, 2026

Got $10,000? Lockheed Martin Could Be a Defense Powerhouse That Outlasts Trump's Term

View original at nasdaq.com
“Net profit margin declined 110 basis points to 8.3%.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Stock Advisor's total average return is 983%, versus 200% for the S&P 500.

    60% confidence
  • Lockheed Martin forecasts full-year 2026 earnings of $29.35 to $30.25 per share, representing approximately 37% growth at the midpoint versus 2025 profits.

    60% confidence
  • Lockheed Martin predicts it will grow sales only 3% to 6% in the first year of its production ramp-up.

    60% confidence
  • Trump called the F-35 Lightning II 'not very good' during his first term and complained about Lockheed Martin's high prices.

    60% confidence
  • Lockheed Martin was not among the 10 best stocks for investors to buy now, per the Motley Fool Stock Advisor analyst team.

    60% confidence
  • Lockheed Martin signed several framework agreements to accelerate and scale munitions production, including advanced Patriot Missile, THAAD, and PrSM.

    60% confidence
  • A $1,000 investment in Nvidia at the time of Motley Fool's April 15, 2005 recommendation would have grown to $1,276,807 as of April 25, 2026.

    60% confidence
  • A $1,000 investment in Netflix at the time of Motley Fool's December 17, 2004 recommendation would have grown to $498,522 as of April 25, 2026.

    60% confidence
  • Lockheed Martin pioneered a number of commercially inspired, long-term business arrangements with US government leadership during Q1 2026.

    60% confidence
  • Annual production rates for at least some of Lockheed Martin's missiles are expected to grow three- or even fourfold under the new multiyear agreements.

    60% confidence
  • Trump vowed to cut the US military budget in half.

    60% confidence

Data points we hold from this source

Lockheed Martin Corporation · capex growth12 percent
Lockheed Martin Corporation · net margin8.3 percent
Lockheed Martin Corporation · revenue analyst consensus18.3 USD
Lockheed Martin Corporation · margin11.7 percent
Lockheed Martin Corporation · capex511 USD
Lockheed Martin Corporation · eps analyst consensus6.74 USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Got $10,000? Lockheed Martin Could Be a Defense Powerhouse That Outlasts Trump's Term — Source | Via News | es.VIA.NEWS